ConductScience.org, home

Paper6709035

Reduction in the size of a pheochromocytoma pulmonary metastasis by metyrosine therapy.

Serri O and 5 others. N Engl J Med, 1984. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. Reduction in the size of a pheochromocytoma pulmonary metastasis by metyrosine therapy. Papers, record 6709035. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6709035

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Reduction in the size of a pheochromocytoma pulmonary metastasis by metyrosine therapy.
PubMed
Journal
N Engl J Med
PubMed
Year
1984
PubMed
Publication types
Case Reports, Letter
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.35
iCite
Revised in PubMed
2004-11-17
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Serri OO
2Comtois RR
3Bettez PP
4Dubuc GG
5Buu NTN T
6Kuchel OO

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lung NeoplasmsMajor topic
MethyltyrosinesMajor topic
PheochromocytomaMajor topic
Adrenal Gland Neoplasms
Aged
Female
Humans
alpha-Methyltyrosine

Source PubMed

Download CSV of topics

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
38377172The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives.Endocr Rev2024https://conductscience.org/library/papers/38377172PubMed
34041599Hypertension in Pheochromocytoma and Paraganglioma: Evaluation and Management in Pediatric Patients.Curr Hypertens Rep2021https://conductscience.org/library/papers/34041599PubMed
25405562Total 18F-FDG PET/CT Metabolic Tumor Volume Is Associated With Postoperative Biochemical Response in Patients With Metastatic Pheochromocytomas and Paragangliomas.Ann Surg2016https://conductscience.org/library/papers/25405562PubMed
1665529[Therapy of a malignant sympathetic paraganglioma of the organ of Zuckerkandl--a case report].Klin Wochenschr1991https://conductscience.org/library/papers/1665529PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6709035

GET https://conductscience.org/api/papers/v1/6709035/authors